Celularity Inc (CELU) KPIs and segments
Close on Nov 12, 2026Market cap $22.22MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Celularity's business
Celularity's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Degenerative Disease($M) | 3.44 | 2.10 | 1.61 | 2.24 | 3.70 | 9.75 | 16.2 | 8.00 | 10.8 | 13.4 | 10.7 | 2.36 | |
Cell Therapy($M) | 1.34 | 0.49 | 1.19 | 1.59 | 0.76 | 0.26 | |||||||
Biobanking($M) | 0.65 | 1.25 | 1.30 | 1.45 | 1.28 | 1.41 | 1.28 | 1.29 | 1.28 | 1.29 | 1.38 | 1.43 | |
Product($M) | 4.06 | 0.87 | 0.88 | 0.89 | 2.38 | 9.02 | 9.14 | 3.39 | 9.96 | 12.8 | 9.52 | 1.68 | |
Processing and Storage Fees, Net($M) | 1.45 | 1.28 | 1.41 | 1.29 | 1.28 | 1.29 | |||||||
License Royalty and Other($M) | 0.72 | 1.73 | 1.92 | 2.94 | 2.08 | 1 | 7.71 | 4.61 | 0.87 | 0.55 | 1.22 | 0.68 | |
Service($M) | 0.65 | 1.25 | 1.30 | 1.45 | 1.28 | 1.41 | 1.28 | 1.29 | 1.28 | 1.29 | 1.38 | 1.43 | |
Degenerative Disease($M) | 1.10 | -0.72 | -10.5 | -2.80 | -3.17 | 1.66 | 2.58 | 0.17 | 3.46 | 7.52 | -1.50 | -2.75 | |
Biobanking($M) | 0.26 | 0.79 | 0.84 | 0.86 | 0.67 | 0.83 | 0.61 | 0.70 | 0.29 | 0.69 | 0.11 | 0.68 | |
Cell Therapy($M) | -0.47 | -1.97 | -1.74 | -2.49 | -2.17 | -2.99 | -2.74 | -3.50 | -3.42 | -5.47 | 24.8 | -4.89 | |
Other($M) | -4.77 | -7.86 | -8.10 | -10.8 | -9.62 | -8.53 | -10.1 | -9.58 | -9.40 | -9.07 | |||
Degenerative Disease($M) | 1.32 | 0.87 | -5.55 | -1.44 | -1.32 | 6.41 | 9.04 | 4.36 | 9.25 | 11.9 | 1.42 | -0.85 | |
Biobanking($M) | 0.43 | 1.03 | 1.09 | 1.23 | 1.06 | 1.20 | 1.06 | 1.05 | 0.74 | 1.11 | 1.08 | 1.03 | |
Product($M) | 1.99 | 0.69 | -5.25 | -0.77 | -0.17 | 6.51 | 7.10 | 2.85 | 8.84 | 11.6 | 2.37 | 1.13 | |
License Royalty and Other($M) | 0.67 | 0.67 | 0.89 | 0.92 | -0.39 | 0.16 | 2.63 | 1.51 | 0.40 | 0.31 | -0.96 | -1.97 | |
Service($M) | 0.43 | 1.03 | 1.09 | 1.23 | 1.06 | 1.20 | 1.06 | 1.05 | 0.74 | 1.11 | 1.08 | 1.03 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-10-20.
See a number that looks wrong?